A recent study has found that the diabetes drug tirzepatide helps people with type 2 diabetes lower their blood sugar and ...
Gastrointestinal adverse events partially mediated the weight loss effects among patients with obesity who received tirzepatide vs placebo.
Weight-loss drugs are now classed as "high risk" medicines, requiring extra safeguards, and are offered on the NHS with ...
New restrictions and safety checks on online pharmacies that prescribing high risk drugs, such as the weight loss drugs semaglutide and tirzepatide, could have a “significant” impact on GPs’ workload, ...